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Efficacies of fenbendazole and 
albendazole in the treatment of 
commercial turkeys artificially 
infected with Ascaridia dissimilis
Jessica Perkins*, Thomas Yazwinski†, and Chris Tucker§
ABSTRACT
The goal of this research was to determine the extent of resistance that turkey roundworms, Asca-
ridia dissimilis, have developed to anti-parasitic chemicals used in commercial poultry operations.  
Roundworm infections in turkeys have resulted in monetary losses for the poultry industry for 
years, generally due to poor feed conversion. The infection itself is subclinical and many turkeys 
have a light to moderate worm burden. Since parasitisms are light, this leads to the infections being 
noticed only during processing. Ascaridia dissimilis infections consist of adult worms and develop-
ing larvae with the latter comprising most of the worm burden and causing the most damage. In 
this study, eggs were collected from A. dissimilis found in turkeys previously treated with various 
parasiticides and combinations thereof. These eggs were in turn used to instill artificial infections in 
turkeys on site. These artificially infected turkeys were then treated with fenbendazole or albenda-
zole. A third group of birds was left untreated as a control group. Drug efficacies were determined 
based on parasite loads post treatment (at necropsy). The results of this study will improve current 
knowledge of chemical resistance associated with these drugs.  
* Jessica Perkins is a senior with a major in Animal Science. 
† Tom Yazwinski, the faculty mentor, is a university professor in the Department of Animal Science.
§ Chris Tucker is a program assistant in the Department of Animal Science. 
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INTRODUCTION
The economic losses due to infections by Ascaridia 
dissimilis can be significant. Poor feed conversion makes 
it difficult for turkeys to gain weight. This results in low 
market weight and in some extreme cases, it can result in 
damaged livers that cannot be sold, contributing to even 
lower profits (Willoughby et al., 1995).
Turkey producers have been using numerous chemical 
parasiticides for treating A. dissimilis throughout the years, 
all with varying success rates. Poor results with anthelmin-
tic drugs are often related to chemical resistance. Resis-
tance results from a product killing off a large percentage 
of the worm population, but leaving a very small percent-
age that may not be susceptible to that particular product. 
This resistant population continues to reproduce, creating 
a new population of worms that are not affected by the 
product. 
Ascaridia dissimilis has a direct life cycle with no inter-
mediate host. The eggs (Fig. 1) are laid by adults in the in-
testines and are shed into the environment through drop-
pings. Larvae develop inside the eggs and become infective 
within a few weeks (Seaton et al., 2001).
The first larval stage is developed inside the egg after 
approximately one week. After another 20 days, the larva 
develops into second-stage larvae (Fig. 2), which is infec-
tive to the turkey (Seaton et al., 2001). After ingestion, the 
larvae emerge from the eggs in the anterior portion of 
the intestinal tract, and localize against the mucosa in the 
small intestine. After approximately two weeks, they molt 
to the third-stage with some larvae migrating into the mu-
cosa and submucosa (“tissue phase”) while the remainder 
of the larvae stay in the mucus. After another two to three 
weeks, the larvae develop into fourth-stage larvae which in 
turn develop into adults. With naturally infected birds, a 
residual population of third-stage larvae is maintained. 
Damage to the mucosa can result in hemorrhagic en-
teritis. Nutrients are not digested well, contributing to 
poor feed conversion and low market weight (Willoughby 
et al., 1995). Occasionally, A. dissimilis larvae have been 
observed in the livers of turkeys, causing an immune re-
sponse that results in 1-mm white spots on the surface of 
the liver (Aziz and Norton, 2004). With heavy infections, 
the migration of developing larvae in the mucosa can re-
sult in death and adults can block the intestinal lumen 
(Yazwinski, 1999).
The piperazine salt anthelmintics are only partially 
effective against adult worms and repeat treatment is re-
quired for any real benefit to the bird. These drugs have 
been overused throughout the years and studies have re-
vealed that piperazine severely lacks efficacy (Yazwinski, 
1999).
Fenbendazole is a benzimidazole anthelmintic used 
to treat birds for helminth infections. It is FDA approved 
for turkeys and has long been considered effective against 
both the larvae and the adult worms. Recently, poultry 
MEET THE STUDENT-AUTHOR
I grew up in Siloam Springs, Arkansas and graduated from Siloam 
Springs High School in 2006. After graduation, I moved to Pennsyl-
vania to study liberal arts. Upon realizing my mistake, I moved back 
home and began studying Animal Science at the University of Arkan-
sas in 2009. I am the treasurer for the Pre-Veterinary club on campus 
and I hope to attend veterinary school in the fall of 2013. Currently I 
reside in Fayetteville with my two simple dogs and very malevolent cat. 
In my free time I enjoy knitting, advocating women’s rights, and look-
ing at funny pictures of cats on the internet.
I would like to thank Tom Yazwinski for his support and patience 
throughout this project, as well as Chris Tucker for teaching me how to 
properly dissect a turkey gut. I would also like to thank Nick Anthony 
and Duane Wolf for their encouragement throughout my time in the 
Honors program.
Jessica Perkins
The STudenT Journal of dale BumperS College of agriCulTural, food and life SCienCeS 63
producers have begun to notice increased resistance to it 
(pers. comm.). No studies have been published as of yet 
regarding the current efficacy of fenbendazole in turkeys. 
This study will therefore provide timely information on 
the effectiveness of this product. 
Albendazole is another benzimidazole anthelmintic 
used to remove gastrointestinal worms. It is a “prescrip-
tion only” drug for poultry and has not been evaluated 
by the FDA for use in commercial turkeys to treat ascarid 
infections (Tucker et al., 2007). Albendazole and fenben-
dazole both work through inhibiting microtubule polym-
erization. This restricts nematode glucose uptake and the 
worms lack the energy to survive. 
The current study was conducted so that a current 
evaluation of drug efficacies might be obtained. This in-
formation is essential for the control of turkey ascaridiasis, 
a common condition of turkeys that is of animal health 
and producer profit significance.
MATERIALS AND METHODS
Collection and Incubation of Ascaridia Dissimilis Eggs.
Approximately one hundred intestinal tracts containing A. 
dissimilis were shipped overnight to the University of Ar-
kansas from four separate turkey operations in the USA. 
Each turkey operation used a different chemical regimen 
for treating ascarid infections. The intestinal tracts were 
cut open lengthwise, the contents removed and sieved, and 
all mature female A. dissimilis were collected. Eggs were re-
moved from the uteri of the female A. dissimilis, washed 
and incubated at 30 °C in water until reaching the infective 
larval stage.
Brooding and Infection of Turkeys. One hundred and 
fifty, one-day-old turkeys were obtained from Cargill in 
Gentry, Ark. and brought back to a University of Arkan-
sas poultry growing facility. At 7 days of age, each bird 
was wing tagged with a unique identification number. 
Throughout brooding, the turkeys were moved into new 
pens to allow for adequate space. 
At 14 days of age, and again at 28 days of age, birds were 
orally gavaged with source specific infective eggs of A. dis-
similis (approximately 40 birds per source and 1000 eggs 
per dose). At 45 days of age, birds were treated according 
to random selection within each infection source group. 
Treatments equally applied per group were fenbendazole 
suspension (5 mg/kg BW), albendazole suspension (5 mg/
kg BW) and control (no treatment) (Table 1). For each 
benzimidazole, a stock solution with a concentration of 
5 mg/ml was made from commercially available products 
(10% fenbendazole suspension [Safeguard], 11.36% al-
bendazole solution [Valbazen]). On the day of treatment, 
each bird was weighed and treated at the volumetric rate 
of 1 ml/kg BW, with the total dose given in halves with a 
6-hr interval. Humane euthanasia by cervical dislocation 
occurred at 52 days of age. The intestinal tracts were re-
moved from the duodenal/gizzard junction to the rectum 
as per World Association for the Advancement of Veteri-
nary Parasitology (WAAVP) efficacy evaluation guidelines 
(Yazwinski et al., 2003) and sent to the parasitology lab at 
the University of Arkansas to be processed for nematode 
enumeration.
Quantification of Ascaridia dissimilis. Intestinal tracts 
from the study birds were cut open lengthwise and soaked 
overnight to optimize nematode collection. After soaking, 
the intestines were drawn through a tightly clenched fist to 
remove all contents. These contents were then washed over 
a number 200 sieve (aperture of 75 µm). All A. dissimilis 
recovered were identified and counted to developmental 
stage with stereoscopic microscopes at 4-30× magnifica-
tion. 
Statistics. Individual bird infections by A. dissimilis 
(adult and larval forms combined) were transformed to 
the log
10
(X + 1) prior to analysis of variance to test for 
group mean separations at the 5% level of probability. 
This transformation is the norm for data sets where large 
variability is encountered among individual counts within 
populations. Data are presented as arithmetic means and 
geometric means, with the latter given with significant 
mean separations. The following standard equation was 
used to calculate efficacy percentages:
% efficacy = 
€ 
[control group geometric mean− treatment group geometric mean]




Data were organized per infection source and treat-
ment group with attention given to total larval ascarids, 
total adult ascarids, total (combined larval and adult 
stages) worm burdens, average worm burdens and overall 
efficacy of treatment based on geometric means for total 
worm burdens. In Table 2, the nematode burden arith-
metic means by infection source and treatment group are 
presented for adult, larval and combined infections. Light 
infections were seen for all stages of A. dissimilis, regardless 
of source or infection group. Judging from the data in Ta-
ble 2, it is apparent that good infections were obtained for 
all source infections and that considerable range in worm 
counts was seen for each source × treatment group popu-
lation (standard deviations were usually equal to arithme-
tic means). Geometric means for total worm burdens as 
seen for the 12 experimental groups are presented in Table 
3. Significant (P < 0.05) treatment effect was seen for in-
fections sourced from producers A and B. Worm burdens 
from all 4 source infections were not significantly different 
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dependent on benzimidazole evaluated, indicating that 
the two anthelmintics used in this study did not signifi-
cantly differ in efficacies.  
According to WAAVP standards, to be considered “ef-
fective”, anthelmintic drugs must have a >90% efficacy 
(Yazwinski et al., 2003). As seen in Table 4, only albenda-
zole treatment given for source B infections can be consid-
ered efficacious in the current study. In previous studies, 
fenbendazole was demonstrated to be 97% to 99% effec-
tive against all stages of A. dissimilis (Yazwinski, 1993 and 
2009). In comparison, birds treated with fenbendazole 
in this study had dramatically lower efficacy percentages 
(source dependent efficacies of 26.8%, 54.9%, 80.9% and 
83.6%). Albendazole efficacies displayed in the current 
study by infection source were 0, 5.1%, 78.3% and 92.3%.
The less than efficacious anthelmintic efficacies of 
fenbendazole and albendazole as seen in this study may 
indicate a rising resistance to benzimidazoles in A. dis-
similis populations. Resistance in a pathogen population 
to chemicals used for control is a natural result of most 
intervention programs. Given the apparent reduction of 
benzimidazole efficacies in the treatment of A. dissimilis 
infections, altered or different treatments must be investi-
gated so that this common disease condition of commer-
cial turkeys might once again be effectively controlled. 
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Fig. 1. Ascaridia dissimilis egg. 
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Figure 2: Parasitic, life stages of Ascaridia dissimilis 
 
Fig. 2. Parasitic, life stages of Ascaridia dissimilis. 
Table 1. Description of experimental groups used in this study. 
Source* Field treatment Birds per group Study treatment 






























*Letters denote the commercial turkey operation from which the source infections originated. 
 
Table 2. Arithmetic means (SD) for adult and larval (L4 and L3) Ascaridia dissimilis 
populations by source of infection and treatment group. 
Source* Treatment A. dissimilis as: 



















































*Letters denote the commercial turkey operation from which the source infections originated. 
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Table 3. Geometric means for Ascaridia dissimilis (adult and larval stages combined) 
by source of infection and treatment group. 
 Treatment Group 













C 13.82 17.45 10.14 
D 5.10 4.84 2.30 
a,b
 Means in the same row with different superscripts are different (P < 0.05). 
*Letters denote the commercial turkey operation from which the source infections originated. 
 
 
Table 4. Percent efficacies against Ascaridia dissimilis by source of infection 
and treatment (based on geometric means). 
 % efficacy for 
Source* Albendazole Fenbendazole 
A 78.3 80.9 
B 92.3 83.6 
C 0.0 26.8 
D 5.1 54.9 
* Letters denote the commercial turkey operation from which the source infections originated. 
 
